688046 药康生物
2024/09 - 九个月
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资82,33818.99%69,19868,53630,0770
投资性房地产7,949--0000
固定资产490,4530.77%486,699194,079175,959159,540
在建工程91,6802.32%89,603171,67053,0152,899
无形资产45,933-2.97%47,34148,51449,53541,199
商誉0--0000
其他非流动资产137,462-39.50%227,226303,90738,89832,309
855,814-6.98%920,067786,706347,483235,946

流动资产
货币资金490,780-12.39%560,166421,708293,517524,172
应收账款375,99539.57%269,390185,216118,57190,678
存货57,94423.04%47,09249,47130,08417,322
其他流动资产753,008-3.57%780,875810,616264,75415,075
1,677,7271.22%1,657,5231,467,010706,926647,247

流动负债
短期借款68,089-10.59%76,15712,2065,1535,018
应付票据0--0005,000
应付帐款89,653-11.98%101,86050,78761,73041,308
其他流动负债183,644-2.52%188,392151,077124,85298,139
341,385-6.83%366,409214,070191,735149,465
流动资产净值1,336,3423.50%1,291,1141,252,940515,191497,782
资产总额减流动负债2,192,156-0.86%2,211,1812,039,647862,674733,728

非流动负债
长期借款0--0020,0270
应付债券0--0000
其他非流动负债68,841-20.44%86,52461,93357,01476,485
68,841-20.44%86,52461,93377,04176,485

总权益
    实收股本410,0000.00%410,000410,000360,000360,000
    储备项目1,713,314-0.08%1,714,6561,567,714425,633297,244
股东权益2,123,314-0.06%2,124,6561,977,714785,633657,244
非控股权益0--0000